DE69228559T2 - Dna-fragment kodierend für einen tumorzell-proliferationsinhibitierenden faktor - Google Patents

Dna-fragment kodierend für einen tumorzell-proliferationsinhibitierenden faktor

Info

Publication number
DE69228559T2
DE69228559T2 DE69228559T DE69228559T DE69228559T2 DE 69228559 T2 DE69228559 T2 DE 69228559T2 DE 69228559 T DE69228559 T DE 69228559T DE 69228559 T DE69228559 T DE 69228559T DE 69228559 T2 DE69228559 T2 DE 69228559T2
Authority
DE
Germany
Prior art keywords
inhibiting factor
cell proliferation
tumor cell
proliferation inhibiting
dna fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228559T
Other languages
English (en)
Other versions
DE69228559D1 (de
Inventor
Toshi Taisho Pharma Komurasaki
Hitoshi Taisho Pharmace Toyoda
Makoto Taisho Pharma Yoshimoto
Kazunori Taisho Pharmac Hanada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69228559D1 publication Critical patent/DE69228559D1/de
Publication of DE69228559T2 publication Critical patent/DE69228559T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69228559T 1991-12-05 1992-12-03 Dna-fragment kodierend für einen tumorzell-proliferationsinhibitierenden faktor Expired - Fee Related DE69228559T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32192991 1991-12-05
PCT/JP1992/001580 WO1993011233A1 (en) 1991-12-05 1992-12-03 Dna fragment which codes for tumor cell proliferation inhibiting factor

Publications (2)

Publication Number Publication Date
DE69228559D1 DE69228559D1 (de) 1999-04-08
DE69228559T2 true DE69228559T2 (de) 1999-06-17

Family

ID=18137997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228559T Expired - Fee Related DE69228559T2 (de) 1991-12-05 1992-12-03 Dna-fragment kodierend für einen tumorzell-proliferationsinhibitierenden faktor

Country Status (10)

Country Link
US (1) US5523391A (de)
EP (1) EP0617122B1 (de)
JP (1) JP2784264B2 (de)
KR (1) KR100239335B1 (de)
AT (1) ATE177146T1 (de)
AU (1) AU666689B2 (de)
CA (1) CA2124941C (de)
DE (1) DE69228559T2 (de)
ES (1) ES2130185T3 (de)
WO (1) WO1993011233A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029340A1 (fr) * 1993-06-04 1994-12-22 Taisho Pharmaceutical Co., Ltd. Facteur d'inhibition de la proliferation de cellules tumorales d'origine humaine
US8294552B2 (en) * 2001-07-10 2012-10-23 Xatra Fund Mx, Llc Facial scan biometrics on a payment device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
JP2784272B2 (ja) * 1990-06-06 1998-08-06 大正製薬株式会社 腫瘍細胞増殖阻害因子
US5281520A (en) * 1990-09-12 1994-01-25 Zymogenetics, Inc. Method for producing acyloxyacyl hydrolase

Also Published As

Publication number Publication date
JP2784264B2 (ja) 1998-08-06
AU666689B2 (en) 1996-02-22
CA2124941C (en) 2002-07-23
EP0617122A4 (de) 1995-06-07
AU3094692A (en) 1993-06-28
ES2130185T3 (es) 1999-07-01
KR100239335B1 (ko) 2000-01-15
US5523391A (en) 1996-06-04
EP0617122B1 (de) 1999-03-03
EP0617122A1 (de) 1994-09-28
WO1993011233A1 (en) 1993-06-10
ATE177146T1 (de) 1999-03-15
DE69228559D1 (de) 1999-04-08
CA2124941A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
ATE535615T1 (de) Chemisch modifizierte nukleinsäuren und methode zur kopplung von nukleinsäuren an einen festen träger
DE69943286D1 (de) Fluoreszierende proteine aus nicht-biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
NO20043419L (no) Nytt cytokin, zcytor17-ligand
IS5802A (is) Greining genavirkni með hindrun tvíþátta RNA
DE69523586D1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
ATE177146T1 (de) Dna-fragment kodierend für einen tumorzell- proliferationsinhibitierenden faktor
DK0672124T3 (da) Anvendelse af en DNA-sekvens, der koder for et oxalsyre-nedbrydende protein i form af et selektionsgen
EP0643719A4 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen.
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
KR960702849A (ko) 사람유래 종양세포 증식저해 인자
DK1123396T3 (da) Minimale promotorer og anvendelser deraf
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
ATE261436T1 (de) Verfahren zu herstellung von substituierten pyranen
EP1293538A3 (de) Verfahren zur Herstellung von Styrylfarbstoffen
EP1001540A3 (de) Verfahren und Vorrichtung zur Blockkodierung
DE69519654T2 (de) htFIIIA Gen
AU8643491A (en) Method for fast sequencing of linear and ordered biological sequences
ATE342941T1 (de) Mit aktinischer strahlung härtbare masse, verfahren zu ihrer herstellung und ihre verwendung
ATE316566T1 (de) Verfahren zur reinigung von lankettigen alkylphenolen und mannich-addukten davon
IT1256078B (it) Ligandi kit solubili
RU97108902A (ru) Способ защиты стали от кислотной коррозии
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie
ES1020910U (es) Antena para emision de onda media.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee